Marker Therapeutics, Inc.
MRKR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,999 | -$4,016 | -$4,446 | -$3,838 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $14 | $379 | $51 |
| Change in WC | -$770 | $2,123 | -$1,433 | -$916 |
| Other Non-Cash | $33 | $0 | $0 | $0 |
| Operating Cash Flow | -$2,736 | -$1,878 | -$5,500 | -$4,703 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,864 | $0 | $1 | $14,892 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $4 |
| Financing Cash Flow | $9,864 | $0 | $1 | $14,896 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $7,128 | -$1,878 | -$5,499 | $10,193 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,815 | $13,693 | $19,192 | $9,000 |
| End Cash | $18,943 | $11,815 | $13,693 | $19,192 |
| Free Cash Flow | -$2,736 | -$1,878 | -$5,500 | -$4,703 |